Nancy Stuart, Chief Operating Officer at CONCERT PHARMACEUTICALS, INC. (CNCE), sold 13,200 shares at $8.35 ($110K) on 2023-01-30, disclosed to the SEC on 2023-01-31.
Open-market sale of $110k CNCE by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| CNCE | SELL | 2022-02-16 | $19K | — | Filing → |
| CNCE | SELL | 2022-01-07 | $9K | — | Filing → |
| CNCE | SELL | 2021-02-17 | $44K | — | Filing → |